NEUP - MC 12m ,Phase 3 data in Q3 for SAD trial and has Alzheimer drug in Phase 2 partnered with pharma giant Merck .this under radar Company has only 1.88 million outstanding shares if we get positive phase 3 data next quarter this going to explode hard .
AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025
a7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck and in Phase 2 clinical trial in Alzheimer’s